TABLE 1.
Oxaliplatin (n = 27) | Cisplatin (n = 19) | P | ||
---|---|---|---|---|
Age, y | Mean | 62 (12.1) | 61.2 (6.4) | 1.0 |
Median | 64 (25–82) | 61 (52–71) | ||
Race | White | 26 | 18 | 0.42 |
Hispanic | 0 | 1 | ||
Unknown | 1 | 0 | ||
Body mass index | Mean | 29.8 (6.2) | 27.5 (6) | 0.83 |
Median | 30.8 (19.3–41.3) | 26.5 (19.3–38) | ||
Cancer type | Ovary fallopian tube, primary peritoneal | 23 | 16 | 0.23 |
Endometrium | 4 | 1 | ||
Cervix | 0 | 2 | ||
Histology type | Carcinosarcoma | 1 | 0 | 0.52 |
Nonserous | 4 | 1 | ||
Serous | 20 | 15 | ||
Squamous cell | 0 | 1 | ||
Unknown | 2 | 2 | ||
Cytoreduction | Optimal | 22 | 10 | 0.17 |
Suboptimal | 2 | 4 | ||
Unknown | 3 | 5 |